Skip to main content
Rebecca Klisovic, MD, Oncology, Cleveland, OH, University Hospitals Cleveland Medical Center

RebeccaB.KlisovicMD

Oncology Cleveland, OH

Hematologic Oncology

Assistant CMIO UH Seidman Cancer Professor - Hematology & Oncology

Dr. Klisovic is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Klisovic's full profile

Already have an account?

  • Office

    UH Cleveland Medical Center
    11100 Euclid Ave Department of Medicine-Hematology and Oncology
    Cleveland, OH 44106
    Phone+1 216-844-3951
    Fax+1 216-844-5234
  • Is this information wrong?

Education & Training

  • Ohio State University Hospital
    Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2001 - 2004
  • University of North Carolina Hospitals
    University of North Carolina HospitalsResidency, Internal Medicine, 1997 - 2000
  • Ohio State University College of Medicine
    Ohio State University College of MedicineClass of 1997
  • Case Western Reserve University
    Case Western Reserve UniversityBS, Biomedical Engineering, 1989 - 1993

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2001 - 2025
  • GA State Medical License
    GA State Medical License 2017 - 2022
  • NC State Medical License
    NC State Medical License 1998 - 2001
  • American Board of Internal Medicine Medical Oncology
  • EpicPhysician Builder

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Results of SWOG 1318: A Phase 2 Trial of Blinatumomab Followed By Pomp (Prednisone, Vincristine, Methotrexate, 6-Mercaptopurine) Maintenance in Elderly Patients with N... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Authored Content

  • Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 MutationJune 2017

Press Mentions

  • OncLive® Presents State of the Science Summit™ on Hematologic Malignancies
    OncLive® Presents State of the Science Summit™ on Hematologic MalignanciesOctober 31st, 2019
  • Turning Points: Together in Sickness, Married in Health
    Turning Points: Together in Sickness, Married in HealthAugust 1st, 2016
  • Bone-Marrow Donor Travels from Israel for Wedding of Transplant Recipient
    Bone-Marrow Donor Travels from Israel for Wedding of Transplant RecipientApril 29th, 2016
  • Join now to see all

Grant Support

  • Gti-2040: An Anti-Sense Strategy To Reduce Ribonucleotide Reductase In AMLNational Cancer Institute2009–2010

Professional Memberships

Hospital Affiliations